IL-17 links the tumor suppressor LKB1 to gastrointestinal inflammation and polyposis
Science Advances · 2025
DOI: 10.1126/sciadv.adt5933 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Shelby E Compton und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Metabolism and Nutritional Programming, Van Andel Institute, Grand Rapids, MI, USA. Hauptthemen laut MEDLINE: Interleukin-17, Protein Serine-Threonine Kinases, Inflammation, Peutz-Jeghers Syndrome. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
Mutations in the tumor suppressor liver kinase B1 (LKB1) promote the development of gastrointestinal (GI) polyps of unknown etiology. Here, we identify IL-17 as a novel driver of LKB1-dependent polyp growth. GI tumors from mice bearing heterozygous mutations in Stk11 (which encodes LKB1) display signatures of pathogenic IL-17–producing CD4 + T helper 17 (T H 17) cells. LKB1 constrains T cell inflammatory potential, as Stk11 /LKB1 haploinsufficiency promotes T cell differentiation toward pathogenic IL-17–producing T cell lineages (CD4 + T H 17 and CD8 + T c 17) in vitro and following intestinal infection. Mechanistically, aberrant CREB-regulated transcription coactivator 2 (CRTC2)–dependent signaling drives pathogenic T H 17 cell programs downstream of LKB1 haploinsufficiency. Targeting this circuit via CRTC2 deletion or IL-17 blockade antagonizes GI polyp growth in mouse models of Peutz-Jeghers syndrome. These findings establish LKB1 as a gatekeeper of inflammatory type 3 (IL-17–dependent) T cell responses and identify a CRTC2–IL-17 signaling axis that can be targeted therapeutically to block the growth of LKB1 mutant GI tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Metabolism and Nutritional Programming, Van Andel Institute, Grand Rapids, MI, USA.
- Bioinformatics and Biostatistics Core, Van Andel Institute, Grand Rapids, MI, USA.
- Metabolism and Nutrition (MeNu) Program, Van Andel Institute, Grand Rapids, MI, USA.
ORCID-Profile: Shelby E Compton, Brandon M Oswald, Susan M Kitchen-Goosen, Kin H Lau, Michael S Dahabieh, Alexandra Vander Ark, Connie M Krawczyk, Russell G Jones
Förderung
- NIAID NIH HHS
Zitieren
APA
Compton, S. E., DeCamp, L. M., Oswald, B. M., Kitchen-Goosen, S. M., Lau, K. H., Fillinger, R., Dahabieh, M. S., Ark, A. V., Krawczyk, C. M., & Jones, R. G. (2025). IL-17 links the tumor suppressor LKB1 to gastrointestinal inflammation and polyposis. Science Advances. https://doi.org/10.1126/sciadv.adt5933
Vancouver
Compton SE, DeCamp LM, Oswald BM, Kitchen-Goosen SM, Lau KH, Fillinger R, et al. IL-17 links the tumor suppressor LKB1 to gastrointestinal inflammation and polyposis. Science Advances. 2025. doi:10.1126/sciadv.adt5933
BibTeX
@article{Compton2025,
author = {Compton, Shelby E and DeCamp, Lisa M and Oswald, Brandon M and Kitchen-Goosen, Susan M and Lau, Kin H and Fillinger, Robert and Dahabieh, Michael S and Ark, Alexandra Vander and Krawczyk, Connie M and Jones, Russell G},
title = {IL-17 links the tumor suppressor LKB1 to gastrointestinal inflammation and polyposis},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adt5933}
}
EUVIMED